Article date: August 2003
By: B. Shum, S. B. Duffull, P. J. Taylor, S. E. Tett, in Volume 56, Issue 2, pages 188-197
Aim To develop a population pharmacokinetic model for mycophenolic acid in adult kidney transplant recipients, quantifying average population pharmacokinetic parameter values, and between‐ and within‐subject variability and to evaluate the influence of covariates on the pharmacokinetic variability.
Methods Pharmacokinetic data for mycophenolic acid and covariate information were previously available from 22 patients who underwent kidney transplantation at the Princess Alexandra Hospital. All patients received mycophenolate mofetil 1 g orally twice daily. A total of 557 concentration–time points were available. Data were analysed using the first‐order method in NONMEM (version 5 level 1.1) using the G77 FORTRAN compiler.
Results The best base model was a two‐compartment model with a lag time (apparent oral clearance was 27 l h−1, and apparent volume of the central compartment 98 l). There was visual evidence of complex absorption and time‐dependent clearance processes, but they could not be successfully modelled in this study. Weight was investigated as a covariate, but no significant relationship was determined.
Conclusions The complexity in determining the pharmacokinetics of mycophenolic acid is currently underestimated. More complex pharmacokinetic models, though not supported by the limited data collected for this study, may prove useful in the future. The large between‐subject and between‐occasion variability and the possibility of nonlinear processes associated with the pharmacokinetics of mycophenolic acid raise questions about the value of the use of therapeutic monitoring and limited sampling strategies.
DOI: 10.1046/j.1365-2125.2003.01863.x
View this article